Tag: biopharma

Q3 results show strong momentum in YoY-9 month backed by expansion of its anti-microbial portfolio

This 505(B)(2) Oncology product will likely be filed in 2026 and will be offering additional strengths that is intended to provide reduced pill burden, flexibility for dose adjustment

In an exclusive interview, Supriya Kashikar, Founder & CEO, GeNext Genomics shares her insights on the company’s current operations, collaboration with Merck and long-term goals

Revenue from operations at Rs 1,963 Cr, up 17.7% YoY and PAT at 156Cr, up 30.3% YoY

The Cover Story analyzes the Genome India Project and its role in driving self reliance in genomics. Read interviews of Kishore Karumanchi, CEO of aciana. Expert Insights by Pooja Bhatia, Technology Transfer Expert; and Dr Bilal Thangal TM, Medical Lead, NURA. Special Stories on the growing trend of Gut Health testing and HMPV Cases in India.

All ongoing Fibromun trials are expected remain on track with their expected timelines

Will the budget propel India's biotech industry toward becoming a global powerhouse, or are there gaps that need to be addressed? Here’s how the sector is responding.

Chairperson and Managing Director of Biocon welcomed the various initiatives made by the government

Usnoflast is a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS)

The state-of-the-art vaccine manufacturing plant is built to produce 10 different vaccines, and create more than 2000 direct jobs and 1500 indirect employment opportunities